Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 652-668

  Delplace, Vianney ^a,b   Payne, Samantha ^a,b   Shoichet, Molly ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Age related macular degeneration; Age related ocular diseases; Biomaterials; Cell delivery; Diabetic retinopathy; Drug delivery; Glaucoma

Indexed keywords

DRUG DELIVERY; EYE PROTECTION; OPHTHALMOLOGY; TISSUE REGENERATION;

AGE-RELATED MACULAR DEGENERATION; CELL DELIVERY; DIABETIC RETINOPATHY; GLAUCOMA; OCULAR DISEASE;

BIOMATERIALS;

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; BIOMATERIAL; CHITOSAN; CILIARY NEUROTROPHIC FACTOR; CORTICOSTEROID; DEXAMETHASONE; DICLOFENAC; DOXORUBICIN; FLUOCINOLONE ACETONIDE; NEUROTROPHIC FACTOR; NORPHENAZONE; OLIGONUCLEOTIDE PHOSPHOROTHIOATE; PAZOPANIB; PEGAPTANIB; RANIBIZUMAB; SEMAXANIB; SMALL INTERFERING RNA; TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

AGE RELATED MACULAR DEGENERATION; AGING; ARTICLE; CATARACT; CELL TRANSPLANTATION; CORTICOSTEROID THERAPY; DIABETIC RETINOPATHY; DRUG DELIVERY SYSTEM; ELECTRORETINOGRAPHY; EYE DISEASE; GLAUCOMA; HUMAN; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA GANGLION CELL; SCAR FORMATION; VISION; AGE; ANATOMY AND HISTOLOGY; ANIMAL; EYE; EYE DISEASES; METABOLISM;

AGE FACTORS; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL TRANSPLANTATION; DRUG DELIVERY SYSTEMS; EYE; EYE DISEASES; HUMANS;

EID: 84947279691     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.09.065     Document Type: Article

References (253)

1. International Federation of Ageing The High Cost of Low Vision 2013
2. National Center for Health Statistics Summary Health Statistics for U.S. Adults: National Health Interview Survey 2012
3. Canadian Ophthalmological Society The Cost of Vision Loss in Canada 2009
4. M. La Cour, and B. Ehinger The Retina J. Fischbarg, The Biology of the Eye 2006 Elsevier 195 252
5. A. Subrizi, H. Hiidenmaa, T. Ilmarinen, S. Nymark, P. Dubruel, H. Uusitalo, M. Yliperttula, A. Urtti, and H. Skottman Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes Biomaterials 33 2012 8047 8054
6. P.H. Warnke, M. Alamein, S. Skabo, S. Stephens, R. Bourke, P. Heiner, and Q. Liu Primordium of an artificial Bruch's membrane made of nanofibers for engineering of retinal pigment epithelium cell monolayers Acta Biomater. 9 2013 9414 9422
7. M. La Cour, and T. Tongalp The Retinal Pigment Epithelium J. Fischbarg, The Biology of the Eye 2006 Elsevier 253 272
8. J.F. Kiilgaard, and J.P. Koch The Choroid and Optic Nerve Head J. Fischbarg, The Biology of the Eye 2006 Elsevier 273 290
9. D. Ardeljan, and C.C. Chan Aging is not a disease: distinguishing age-related macular degeneration from aging Prog. Retin. Eye Res. 37 2013 68 89
10. World Health Organization Global Data on Visual Impairments 2010 2012
11. T.M. Curtis, T.A. Gardiner, and A.W. Stitt Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond) 23 2009 1496 1508
12. World Health Organization Prevention of Blindness from Diabetes Mellitus 2005
13. AMD.org Dry AMD 2015
14. AMD.org Wet AMD 2015
15. K. Trier The Sclera J. Fischbarg, The Biology of the Eye 2006 Elsevier 353 373
16. M.H. Nissen, and C. Ropke Innate and Adaptive Immunity of the Eye J. Fischbarg, The Biology of the Eye 2006 Elsevier 291 305
17. K.-i. Hosoya, M. Tomi, and M. Tachikawa Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier Expert Opin. Drug Deliv. 8 2011 1571 1587
18. R. Gaudana, H. Ananthula, A. Parenky, and A. Mitra Ocular drug delivery AAPS J. 12 2010 348 360
19. G.P. Mishra, M. Bagui, V. Tamboli, and A.K. Mitra Recent applications of liposomes in ophthalmic drug delivery J. Drug Deliv. 2011 2011 14
20. A. Urtti Challenges and obstacles of ocular pharmacokinetics and drug delivery Adv. Drug Deliv. Rev. 58 2006 1131 1135
21. S.H. Kim, R.J. Lutz, N.S. Wang, and M.R. Robinson Transport barriers in transscleral drug delivery for retinal diseases Ophthalmic Res. 39 2007 244 254
22. J. Barar, A.R. Javadzadeh, and Y. Omidi Ocular novel drug delivery: impacts of membranes and barriers Expert Opin. Drug Deliv. 5 2008 567 581
23. M. Tomi, and K.-i. Hosoya The role of blood-ocular barrier transporters in retinal drug disposition: an overview Exp. Opin. Drug Metabol. Toxicol. 6 2010 1111 1124
24. J. Jordán, and J.M. Ruíz-Moreno Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters Exp. Opin. Drug Metabol. Toxicol. 9 2013 1181 1192
25. D. Pavan-Langston Manual of Ocular Diagnosis and Therapy 6th Edition 2008 Lippincott Williams & Wilkins
26. M.W. Stewart The expanding role of vascular endothelial growth factor inhibitors in ophthalmology Mayo Clin. Proc. 87 2012 77 88
27. D.S. Boyer, J.J. Hopkins, J. Sorof, and J.S. Ehrlich Anti-vascular endothelial growth factor therapy for diabetic macular edema Ther. Adv. Endocrinol. Metab. 4 2013 151 169
28. E.G. Faktorovich, R.H. Steinberg, D. Yasumura, M.T. Matthes, and M.M. LaVail Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor Nature 347 1990 83 86
29. M. Neuner-Jehle, L.V. Berghe, S. Bonnel, Y. Uteza, F. Benmeziane, J.S. Rouillot, D. Marchant, A. Kobetz, J.L. Dufier, M. Menasche, and M. Abitbol Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats Hum. Gene Ther. 11 2000 1875 1890
30. D. Zhang, P.L. Kaufman, G. Gao, R.A. Saunders, and J.X. Ma Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats Diabetologia 44 2001 757 765
31. G. Gao, Y. Li, S. Gee, A. Dudley, J. Fant, C. Crosson, and J.X. Ma Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5 J. Biolumin. Chemilumin. 277 2002 9492 9497
32. R. Wen, W. Tao, Y. Li, and P.A. Sieving CNTF and retina Prog. Retin. Eye Res. 31 2012 136 151
33. E.W. Ng, D.T. Shima, P. Calias, E.T. Cunningham Jr., D.R. Guyer, and A.P. Adamis Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease Nat. Rev. Drug Discov. 5 2006 123 132
34. J.L. Colquitt, J. Jones, S.C. Tan, A. Takeda, A.J. Clegg, and A. Price Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation Health Technol. Assess. 12 2008 ix 201
35. M.W. Stewart Critical appraisal of ranibizumab in the treatment of diabetic macular edema Clin. Ophthalmol. 7 2013 1257 1267
36. S.D. Solomon, K. Lindsley, S.S. Vedula, M.G. Krzystolik, and B.S. Hawkins Anti-vascular endothelial growth factor for neovascular age-related macular degeneration Cochrane Database Syst. Rev. 8 2014 CD005139
37. A. Moss The angiopoietin:tie 2 interaction: a potential target for future therapies in human vascular disease Cytokine Growth Factor Rev. 24 2013 579 592
38. R.J. Santulli, W.A. Kinney, S. Ghosh, B.L. Decorte, L. Liu, R.W. Tuman, Z. Zhou, N. Huebert, S.E. Bursell, A.C. Clermont, M.B. Grant, L.C. Shaw, S.A. Mousa, R.A. Galemmo Jr., D.L. Johnson, B.E. Maryanoff, and B.P. Damiano Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats J. Pharmacol. Exp. Ther. 324 2008 894 901
39. Q.D. Nguyen, R.A. Schachar, C.I. Nduaka, M. Sperling, A.S. Basile, K.J. Klamerus, K. Chi-Burris, E. Yan, D.A. Paggiarino, I. Rosenblatt, R. Aitchison, and S.S. Erlich Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study) Invest. Ophthalmol. Vis. Sci. 53 2012 7666 7674
40. T. Takahashi, T. Nakamura, A. Hayashi, M. Kamei, M. Nakabayashi, A.A. Okada, N. Tomita, Y. Kaneda, and Y. Tano Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells Am J. Ophthalmol. 130 2000 774 781
41. R.K. Vadlapatla, A.D. Vadlapudi, D. Pal, M. Mukherji, and A.K. Mitra Ritonavir inhibits HIF-1alpha-mediated VEGF expression in retinal pigment epithelial cells in vitro Eye (Lond) 28 2014 93 101
42. S.M. Prea, E.C. Chan, G.J. Dusting, A.J. Vingrys, B.V. Bui, and G.S. Liu Gene therapy with endogenous inhibitors of angiogenesis for neovascular age-related macular degeneration: beyond anti-VEGF therapy J. Ophthalmol. 2015 2015 201726
43. S.S. Ghosh, P. Gopinath, and A. Ramesh Adenoviral vectors: a promising tool for gene therapy Appl. Biochem. Biotechnol. 133 2006 9 29
44. R. Khare, C.Y. Chen, E.A. Weaver, and M.A. Barry Advances and future challenges in adenoviral vector pharmacology and targeting Curr. Gene Ther. 11 2011 241 258
45. N. Tatsis, and H.C.J. Ertl Adenoviruses as vaccine vectors Mol. Ther. 10 2004 616 629
46. N. Haghjou, M. Soheilian, and M.J. Abdekhodaie Sustained release intraocular drug delivery devices for treatment of uveitis J. Ophthalmic. Vis. Res. 6 2011 317 329
47. F.E. Kane, J. Burdan, A. Cutino, and K.E. Green Iluvien: a new sustained delivery technology for posterior eye disease Expert Opin. Drug Deliv. 5 2008 1039 1046
48. Iluvien 190 Micrograms Intravitreal Implant in Applicator Public Assessment Report Medicines and Healthcare products Regulatory 2012
49. I. Allergan OZURDEX® (Dexamethasone Intravitreal Implant) For Intravitreal Injection 2014
50. S.J. Bakri, and A.F. Omar Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion J. Ocul. Pharmacol. Ther. 28 2012 547 549
51. Bausch & Lomb Incorporated Product Monogram RETISERT™ 2008
52. G.J. Jaffe, D. Martin, D. Callanan, P.A. Pearson, B. Levy, and T. Comstock Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study Ophthalmology 113 2006 1020 1027
53. V.S. Sangwan, P.A. Pearson, H. Paul, and T.L. Comstock Use of the fluocinolone acetonide intravitreal implant for the treatment of noninfectious posterior uveitis: 3-year results of a randomized clinical trial in a predominantly Asian population Ophthalmol. Ther. 4 2015 1 19
54. M.P. Zanin, L.N. Pettingill, A.R. Harvey, D.F. Emerich, C.G. Thanos, and R.K. Shepherd The development of encapsulated cell technologies as therapies for neurological and sensory diseases J. Control. Release 160 2012 3 13
55. W. Tao, R. Wen, M.B. Goddard, S.D. Sherman, P.J. O'Rourke, P.F. Stabila, W.J. Bell, B.J. Dean, K.A. Kauper, V.A. Budz, W.G. Tsiaras, G.M. Acland, S. Pearce-Kelling, A.M. Laties, and G.D. Aguirre Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa Invest. Ophthalmol. Vis. Sci. 43 2002 3292 3298
56. C.G. Thanos, W.J. Bell, P. O'Rourke, K. Kauper, S. Sherman, P. Stabila, and W. Tao Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device Tissue Eng. 10 2004 1617 1622
57. P.A. Sieving, R.C. Caruso, W. Tao, H.R. Coleman, D.J. Thompson, K.R. Fullmer, and R.A. Bush Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants Proc. Natl. Acad. Sci. U. S. A. 103 2006 3896 3901
58. K. Kauper, C. McGovern, S. Sherman, P. Heatherton, R. Rapoza, P. Stabila, B. Dean, A. Lee, S. Borges, B. Bouchard, and W. Tao Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases Invest. Ophthalmol. Vis. Sci. 53 2012 7484 7491
59. D.G. Birch, R.G. Weleber, J.L. Duncan, G.J. Jaffe, and W. Tao Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa Am J. Ophthalmol. 156 2013 283 292
60. http://www.neurotechusa.com/ect-platform.html
61. U.B. Kompella, A.C. Amrite, R. Pacha Ravi, and S.A. Durazo Nanomedicines for back of the eye drug delivery, gene delivery, and imaging Prog. Retin. Eye Res. 36 2013 172 198
62. A. Bochot, and E. Fattal Liposomes for intravitreal drug delivery: a state of the art J. Control. Release 161 2012 628 634
63. J.J. Kang-Mieler, C.R. Osswald, and W.F. Mieler Advances in ocular drug delivery: emphasis on the posterior segment Exp. Opin. Drug Deliv. 11 2014 1647 1660
64. J. Araujo, S. Nikolic, M.A. Egea, E.B. Souto, and M.L. Garcia Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye Colloids Surf. B: Biointerfaces 88 2011 150 157
65. J. Araujo, M.L. Garcia, M. Mallandrich, E.B. Souto, and A.C. Calpena Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies Nanomedicine 8 2012 1034 1041
66. K. Park, Y. Chen, Y. Hu, A.S. Mayo, U.B. Kompella, R. Longeras, and J.X. Ma Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage Diabetes 58 2009 1902 1913
67. J. Jin, K.K. Zhou, K. Park, Y. Hu, X. Xu, Z. Zheng, P. Tyagi, U.B. Kompella, and J.X. Ma Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor Invest. Ophthalmol. Vis. Sci. 52 2011 6230 6237
68. H.A. Liu, Y.L. Liu, Z.Z. Ma, J.C. Wang, and Q. Zhang A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model Invest. Ophthalmol. Vis. Sci. 52 2011 4789 4794
69. I. Pepic, A. Hafner, J. Lovric, B. Pirkic, and J. Filipovic-Grcic A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation J. Pharm. Sci. 99 2010 4317 4325
70. R.J. Marano, I. Toth, N. Wimmer, M. Brankov, and P.E. Rakoczy Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity Gene Ther. 12 2005 1544 1550
71. R.J. Marano, N. Wimmer, P.S. Kearns, B.G. Thomas, I. Toth, M. Brankov, and P.E. Rakoczy Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide Exp. Eye Res. 79 2004 525 535
72. M. Abrishami, S. Zarei-Ghanavati, D. Soroush, M. Rouhbakhsh, M.R. Jaafari, and B. Malaekeh-Nikouei Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration Retina 29 2009 699 703
73. J.J. Panda, S. Yandrapu, R.S. Kadam, V.S. Chauhan, and U.B. Kompella Self-assembled phenylalanine-alpha,beta-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor J. Control. Release 172 2013 1151 1160
74. C. Civiale, M. Licciardi, G. Cavallaro, G. Giammona, and M.G. Mazzone Polyhydroxyethylaspartamide-based micelles for ocular drug delivery Int. J. Pharm. 378 2009 177 186
75. F. Rafie, Y. Javadzadeh, A.R. Javadzadeh, L.A. Ghavidel, B. Jafari, M. Moogooee, and S. Davaran In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye Curr. Eye Res. 35 2010 1081 1089
76. M. Tanito, K. Hara, Y. Takai, Y. Matsuoka, N. Nishimura, P. Jansook, T. Loftsson, E. Stefansson, and A. Ohira Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema Invest. Ophthalmol. Vis. Sci. 52 2011 7944 7948
77. K. Hironaka, Y. Inokuchi, T. Fujisawa, H. Shimazaki, M. Akane, Y. Tozuka, K. Tsuruma, M. Shimazawa, H. Hara, and H. Takeuchi Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage Eur. J. Pharm. Biopharm. 79 2011 119 125
78. H. Shimazaki, K. Hironaka, T. Fujisawa, K. Tsuruma, Y. Tozuka, M. Shimazawa, H. Takeuchi, and H. Hara Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice Invest. Ophthalmol. Vis. Sci. 52 2011 7289 7297
79. C.W. Chen, D.W. Lu, M.K. Yeh, C.Y. Shiau, and C.H. Chiang Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells Int. J. Nanomedicine 6 2011 2567 2580
80. C.W. Chen, M.K. Yeh, C.Y. Shiau, C.H. Chiang, and D.W. Lu Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery Int. J. Nanomedicine 8 2013 2613 2627
81. M. Honda, T. Asai, T. Umemoto, Y. Araki, N. Oku, and M. Tanaka Suppression of choroidal neovascularization by intravitreal injection of liposomal SU5416 Arch. Ophthalmol. 129 2011 317 321
82. J.L. Wang, Y.L. Liu, Y. Li, W.B. Dai, Z.M. Guo, Z.H. Wang, and Q. Zhang EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats Invest. Ophthalmol. Vis. Sci. 53 2012 7348 7357
83. D. Meisner, and M. Mezei Liposome ocular delivery systems Adv. Drug Deliv. Rev. 16 1995 75 93
84. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Deliv. Rev. 65 2013 36 48
85. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 Am J. Ophthalmol. 131 2001 541 560
86. S.R. Singh, H.E. Grossniklaus, S.J. Kang, H.F. Edelhauser, B.K. Ambati, and U.B. Kompella Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV Gene Ther. 16 2009 645 659
87. L. Luo, X. Zhang, Y. Hirano, P. Tyagi, P. Barabas, H. Uehara, T.R. Miya, N. Singh, B. Archer, Y. Qazi, K. Jackman, S.K. Das, T. Olsen, S.R. Chennamaneni, B.C. Stagg, F. Ahmed, L. Emerson, K. Zygmunt, R. Whitaker, C. Mamalis, W. Huang, G. Gao, S.P. Srinivas, D. Krizaj, J. Baffi, J. Ambati, U.B. Kompella, and B.K. Ambati Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration ACS Nano 7 2013 3264 3275
88. B.M. Davis, E.M. Normando, L. Guo, L.A. Turner, S. Nizari, P. O'Shea, S.E. Moss, S. Somavarapu, and M.F. Cordeiro Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes Small 10 2014 1575 1584
89. T. Loftsson, D. Hreinsdottir, and E. Stefansson Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops J. Pharm. Pharmacol. 59 2007 629 635
90. B.D. Kuppermann, M.S. Blumenkranz, J.A. Haller, G.A. Williams, D.V. Weinberg, C. Chou, and S.M. Whitcup Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Arch. Ophthalmol. 125 2007 309 317
91. J.A. Haller, F. Bandello, R. Belfort Jr., M.S. Blumenkranz, M. Gillies, J. Heier, A. Loewenstein, Y.H. Yoon, M.L. Jacques, J. Jiao, X.Y. Li, and S.M. Whitcup Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146
92. R. Herrero-Vanrell, J.A. Cardillo, and B.D. Kuppermann Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema Clin. Ophthalmol. 5 2011 139 146
93. C.A. Arcinue, O.M. Ceron, and C.S. Foster A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis J. Ocul. Pharmacol. Ther. 29 2013 501 507
94. T. Fujisawa, H. Miyai, K. Hironaka, T. Tsukamoto, K. Tahara, Y. Tozuka, M. Ito, and H. Takeuchi Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes Int. J. Pharm. 436 2012 564 567
95. K. Zhang, J.J. Hopkins, J.S. Heier, D.G. Birch, L.S. Halperin, T.A. Albini, D.M. Brown, G.J. Jaffe, W. Tao, and G.A. Williams Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration Proc. Natl. Acad. Sci. U. S. A. 108 2011 6241 6245
96. T. Sakai, N. Kuno, F. Takamatsu, E. Kimura, H. Kohno, K. Okano, and K. Kitahara Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats Invest. Ophthalmol. Vis. Sci. 48 2007 3381 3387
97. X. Xu, Y. Weng, L. Xu, and H. Chen Sustained release of Avastin(R) from polysaccharides cross-linked hydrogels for ocular drug delivery Int. J. Biol. Macromol. 60 2013 272 276
98. C.H. Wang, Y.S. Hwang, P.R. Chiang, C.R. Shen, W.H. Hong, and G.H. Hsiue Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel Biomacromolecules 13 2012 40 48
99. H. Salehi-Had, M.I. Roh, A. Giani, T. Hisatomi, S. Nakao, I.K. Kim, E.S. Gragoudas, D. Vavvas, S. Guccione, and J.W. Miller Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization PLoS One 6 2011 0018864
100. C. Zhang, Y.S. Wang, H. Wu, Z.X. Zhang, Y. Cai, H.Y. Hou, W. Zhao, X.M. Yang, and J.X. Ma Inhibitory efficacy of hypoxia-inducible factor 1alpha short hairpin RNA plasmid DNA-loaded poly (D, l-lactide-co-glycolide) nanoparticles on choroidal neovascularization in a laser-induced rat model Gene Ther. 17 2010 338 351
101. H.A. Quigley Glaucoma Lancet 377 2011 1367 1377
102. A. Heijl, M.C. Leske, B. Bengtsson, L. Hyman, and M. Hussein Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial Arch. Ophthalmol. 120 2002 1268 1279
103. M.C. Leske, A. Heijl, M. Hussein, B. Bengtsson, L. Hyman, and E. Komaroff Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial Arch. Ophthalmol. 121 2003 48 56
104. C. Jiang, M.J. Moore, X. Zhang, H. Klassen, R. Langer, and M. Young Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma Mol. Vis. 13 2007 1783 1792
105. M.A. Kass, D.K. Heuer, E.J. Higginbotham, and et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma Arch. Ophthalmol. 120 2002 701 713
106. F. Wang, L. Chen, D. Zhang, S. Jiang, K. Shi, Y. Huang, R. Li, and Q. Xu Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study J. Drug Target. 22 2014 849 858
107. R. Chen, Y. Qian, R. Li, Q. Zhang, D. Liu, M. Wang, and Q. Xu Methazolamide calcium phosphate nanoparticles in an ocular delivery system Yakugaku Zasshi 130 2010 419 424
108. Y. Qian, F. Wang, R. Li, Q. Zhang, and Q. Xu Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide Drug Dev. Ind. Pharm. 36 2010 1340 1347
109. R. Li, S. Jiang, D. Liu, X. Bi, F. Wang, Q. Zhang, and Q. Xu A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide J. Microencapsul. 28 2011 134 141
110. J. Youshia, A.O. Kamel, A. El Shamy, and S. Mansour Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide Int. J. Nanomedicine 7 2012 2483 2496
111. R.M. Hathout, S. Mansour, N.D. Mortada, and A.S. Guinedi Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies AAPS PharmSciTech 8 2007 1
112. J.V. Natarajan, M. Ang, A. Darwitan, S. Chattopadhyay, T.T. Wong, and S.S. Venkatraman Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye Int. J. Nanomedicine 7 2012 123 131
113. J.V. Natarajan, S. Chattopadhyay, M. Ang, A. Darwitan, S. Foo, M. Zhen, M. Koo, T.T. Wong, and S.S. Venkatraman Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye PLoS One 6 2011 e24513
114. A. Ribeiro, A. Sosnik, D.A. Chiappetta, F. Veiga, A. Concheiro, and C. Alvarez-Lorenzo Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy J. R. Soc. Interface 9 2012 2059 2069
115. H.-R. Lin, and P.-C. Chang Novel pluronic-chitosan micelle as an ocular delivery system J. Biomed. Mater. Res. B Appl. Biomater. 101B 2013 689 699
116. Y. Duan, X. Guan, J. Ge, D. Quan, Y. Zhuo, H. Ye, and T. Shao Cationic nano-copolymers mediated IKKbeta targeting siRNA inhibit the proliferation of human Tenon's capsule fibroblasts in vitro Mol. Vis. 14 2008 2616 2628
117. H. Ye, Y. Qian, M. Lin, Y. Duan, X. Sun, Y. Zhuo, and J. Ge Cationic nano-copolymers mediated IKKbeta targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery Mol. Vis. 16 2010 2502 2510
118. M.F. Cordeiro, A. Mead, R.R. Ali, R.A. Alexander, S. Murray, C. Chen, C. York-Defalco, N.M. Dean, G.S. Schultz, and P.T. Khaw Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome Gene Ther. 10 2003 59 71
119. A.L. Mead, T.T. Wong, M.F. Cordeiro, I.K. Anderson, and P.T. Khaw Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery Invest. Ophthalmol. Vis. Sci. 44 2003 3394 3401
120. A.L. Gomes dos Santos, A. Bochot, A. Doyle, N. Tsapis, J. Siepmann, F. Siepmann, J. Schmaler, M. Besnard, F. Behar-Cohen, and E. Fattal Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery J. Control. Release 112 2006 369 381
121. A.L. Gomes dos Santos, A. Bochot, N. Tsapis, F. Artzner, R.A. Bejjani, B. Thillaye-Goldenberg, Y. de Kozak, E. Fattal, and F. Behar-Cohen Oligonucleotide-polyethylenimine complexes targeting retinal cells: structural analysis and application to anti-TGFbeta-2 therapy Pharm. Res. 23 2006 770 781
122. C. Gomez-Gaete, E. Fattal, L. Silva, M. Besnard, and N. Tsapis Dexamethasone acetate encapsulation into Trojan particles J. Control. Release 128 2008 41 49
123. S.B. Turturro, M.J. Guthrie, A.A. Appel, P.W. Drapala, E.M. Brey, V.H. Perez-Luna, W.F. Mieler, and J.J. Kang-Mieler The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function Biomaterials 32 2011 3620 3626
124. G. Horvat, B. Gyarmati, S. Berko, P. Szabo-Revesz, B.A. Szilagyi, A. Szilagyi, J. Soos, G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, C. Caramella, E. Csanyi, and M. Budai-Szucs Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system Eur. J. Pharm. Sci. 67 2015 1 11
125. S.P. Patel, R. Vaishya, G.P. Mishra, V. Tamboli, D. Pal, and A.K. Mitra Tailor-made pentablock copolymer based formulation for sustained ocular delivery of protein therapeutics J. Drug Deliv. 401747 2014 22
126. H. Yang, P. Tyagi, R.S. Kadam, C.A. Holden, and U.B. Kompella Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration ACS Nano 6 2012 7595 7606
127. R.D. Glickman Ultraviolet phototoxicity to the retina Eye Contact Lens 37 2011 196 205
128. V.A. Huu, J. Luo, J. Zhu, S. Patel, A. Boone, E. Mahmoud, C. McFearin, J. Olejniczak, C. de Gracia Lux, J. Lux, N. Fomina, M. Huynh, K. Zhang, and A. Almutairi Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye J. Control. Release 200 2015 71 77
129. M. Jiang, L. Gan, C. Zhu, Y. Dong, J. Liu, and Y. Gan Cationic core-shell liponanoparticles for ocular gene delivery Biomaterials 33 2012 7621 7630
130. G. Puras, M. Mashal, J. Zarate, M. Agirre, E. Ojeda, S. Grijalvo, R. Eritja, A. Diaz-Tahoces, G. Martinez Navarrete, M. Aviles-Trigueros, E. Fernandez, and J.L. Pedraz A novel cationic niosome formulation for gene delivery to the retina J. Control. Release 174 2014 27 36
131. S. Omri, F. Behar-Cohen, Y. de Kozak, F. Sennlaub, L. Mafra Verissimo, L. Jonet, M. Savoldelli, B. Omri, and P. Crisanti Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the goto Kakizaki rat model Am. J. Pathol. 179 2011 942 953
132. J.L. Santos, Y. Li, H.R. Culver, M.S. Yu, and M. Herrera-Alonso Conducting polymer nanoparticles decorated with collagen mimetic peptides for collagen targeting Chem. Commun. 50 2014 15045 15048
133. Y. Liu, M. Shi, M. Xu, H. Yang, and C. Wu Multifunctional nanoparticles of Fe(3)O(4)@SiO(2)(FITC)/PAH conjugated the recombinant plasmid of pIRSE2-EGFP/VEGF(165) with dual functions for gene delivery and cellular imaging Expert Opin. Drug Deliv. 9 2012 1197 1207
134. A. Subrizi, E. Toropainen, E. Ramsay, A.J. Airaksinen, K. Kaarniranta, and A. Urtti Oxidative stress protection by exogenous delivery of rhHsp70 chaperone to the retinal pigment epithelium (RPE), a possible therapeutic strategy against RPE degeneration Pharm. Res. 32 2015 211 221
135. Y. Mo, M.E. Barnett, D. Takemoto, H. Davidson, and U.B. Kompella Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene Mol. Vis. 13 2007 746 757
136. J. Chen, S. Patil, S. Seal, and J.F. McGinnis Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides Nat. Nanotechnol. 1 2006 142 150
137. X. Zhou, L.L. Wong, A.S. Karakoti, S. Seal, and J.F. McGinnis Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the vldlr knockout mouse PLoS One 6 2011 0016733
138. M.S. Jayaraman, D.J. Bharali, T. Sudha, and S.A. Mousa Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration Mol. Vis. 18 2012 2300 2308
139. J.H. Kim, M.H. Kim, D.H. Jo, Y.S. Yu, and T.G. Lee The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation Biomaterials 32 2011 1865 1871
140. H.-J. Kim, K. Zhang, L. Moore, and D. Ho Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release ACS Nano 8 2014 2998 3005
141. J.S. Wade, and T.A. Desai Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells Biomed. Microdevices 16 2014 629 638
142. S.R. Patel, A.S. Lin, H.F. Edelhauser, and M.R. Prausnitz Suprachoroidal drug delivery to the back of the eye using hollow microneedles Pharm. Res. 28 2011 166 176
143. G. Chatzipirpiridis, O. Ergeneman, J. Pokki, F. Ullrich, S. Fusco, J.A. Ortega, K.M. Sivaraman, B.J. Nelson, and S. Pane Electroforming of implantable tubular magnetic microrobots for wireless ophthalmologic applications Adv. Healthc. Mater. 4 2015 209 214
144. K. Kinnunen, G. Petrovski, M.C. Moe, A. Berta, and K. Kaarniranta Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration Acta Ophthalmol. (Copenh) 90 2012 299 309
145. R.A. Pearson, A.C. Barber, M. Rizzi, C. Hippert, T. Xue, E.L. West, Y. Duran, A.J. Smith, J.Z. Chuang, S.A. Azam, U.F. Luhmann, A. Benucci, C.H. Sung, J.W. Bainbridge, M. Carandini, K.W. Yau, J.C. Sowden, and R.R. Ali Restoration of vision after transplantation of photoreceptors Nature 485 2012 99 103
146. A.C. Barber, C. Hippert, Y. Duran, E.L. West, J.W. Bainbridge, K. Warre-Cornish, U.F. Luhmann, J. Lakowski, J.C. Sowden, R.R. Ali, and R.A. Pearson Repair of the degenerate retina by photoreceptor transplantation Proc. Natl. Acad. Sci. U. S. A. 110 2013 354 359
147. A. Gonzalez-Cordero, E.L. West, R.A. Pearson, Y. Duran, L.S. Carvalho, C.J. Chu, A. Naeem, S.J. Blackford, A. Georgiadis, J. Lakowski, M. Hubank, A.J. Smith, J.W. Bainbridge, J.C. Sowden, and R.R. Ali Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina Nat. Biotechnol. 31 2013 741 747
148. B. Lu, C. Malcuit, S. Wang, S. Girman, P. Francis, L. Lemieux, R. Lanza, and R. Lund Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration Stem Cells 27 2009 2126 2135
149. H. Kamao, M. Mandai, S. Okamoto, N. Sakai, A. Suga, S. Sugita, J. Kiryu, and M. Takahashi Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application Stem Cell Reports 2 2014 205 218
150. B. Mead, A. Logan, M. Berry, W. Leadbeater, and B.A. Scheven Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury Invest. Ophthalmol. Vis. Sci. 54 2013 7544 7556
151. I. Mathivanan, C. Trepp, C. Brunold, G. Baerlocher, and V. Enzmann Retinal differentiation of human bone marrow-derived stem cells by co-culture with retinal pigment epithelium in vitro Exp. Cell Res. 333 2015 11 20
152. L.P. Weiner Definitions and criteria for stem cells Methods Mol. Biol. 438 2008 3 8
153. T.J. Rowland, D.E. Buchholz, and D.O. Clegg Pluripotent human stem cells for the treatment of retinal disease J. Cell. Physiol. 227 2012 457 466
154. S. Arnhold, H. Klein, I. Semkova, K. Addicks, and U. Schraermeyer Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space Invest. Ophthalmol. Vis. Sci. 45 2004 4251 4255
155. V. Tropepe, B.L. Coles, B.J. Chiasson, D.J. Horsford, A.J. Elia, R.R. McInnes, and D. van der Kooy Retinal stem cells in the adult mammalian eye Science 287 2000 2032 2036
156. B.L. Coles, B. Angenieux, T. Inoue, K. Del Rio-Tsonis, J.R. Spence, R.R. McInnes, Y. Arsenijevic, and D. van der Kooy Facile isolation and the characterization of human retinal stem cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 15772 15777
157. J.M. Lawrence, S. Singhal, B. Bhatia, D.J. Keegan, T.A. Reh, P.J. Luthert, P.T. Khaw, and G.A. Limb MIO-M1 cells and similar muller glial cell lines derived from adult human retina exhibit neural stem cell characteristics Stem Cells 25 2007 2033 2043
158. N.D. Bull, G.A. Limb, and K.R. Martin Human Muller stem cell (MIO-M1) transplantation in a rat model of glaucoma: survival, differentiation, and integration Invest. Ophthalmol. Vis. Sci. 49 2008 3449 3456
159. S.S. Park, G. Bauer, M. Abedi, S. Pontow, A. Panorgias, R. Jonnal, R.J. Zawadzki, J.S. Werner, and J. Nolta Intravitreal autologous bone marrow CD34 + cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings Invest. Ophthalmol. Vis. Sci. 56 2014 81 89
160. C. Boucherie, J.C. Sowden, and R.R. Ali Induced pluripotent stem cell technology for generating photoreceptors Regen. Med. 6 2011 469 479
161. D.A. Lamba, A. McUsic, R.K. Hirata, P.R. Wang, D. Russell, and T.A. Reh Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells PLoS One 5 2010 0008763
162. S. Parameswaran, S. Balasubramanian, N. Babai, F. Qiu, J.D. Eudy, W.B. Thoreson, and I. Ahmad Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration Stem Cells 28 2010 695 703
163. E.L. West, A. Gonzalez-Cordero, C. Hippert, F. Osakada, J.P. Martinez-Barbera, R.A. Pearson, J.C. Sowden, M. Takahashi, and R.R. Ali Defining the integration capacity of embryonic stem cell-derived photoreceptor precursors Stem Cells 30 2012 1424 1435
164. H. Kanemura, M.J. Go, M. Shikamura, N. Nishishita, N. Sakai, H. Kamao, M. Mandai, C. Morinaga, M. Takahashi, and S. Kawamata Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration PLoS One 9 2014
165. E.J. van Zeeburg, K.J. Maaijwee, T.O. Missotten, H. Heimann, and J.C. van Meurs A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years Am J. Ophthalmol. 153 2012 120 127
166. L.X. Li, and J.E. Turner Transplantation of retinal pigment epithelial cells to immature and adult rat hosts: short- and long-term survival characteristics Exp. Eye Res. 47 1988 771 785
167. M.M. Lavail, L. Li, J.E. Turner, and D. Yasumura Retinal pigment epithelial cell transplantation in RCS rats: normal metabolism in rescued photoreceptors Exp. Eye Res. 55 1992 555 562
168. A. Vugler, A.J. Carr, J. Lawrence, L.L. Chen, K. Burrell, A. Wright, P. Lundh, M. Semo, A. Ahmado, C. Gias, L. da Cruz, H. Moore, P. Andrews, J. Walsh, and P. Coffey Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation Exp. Neurol. 214 2008 347 361
169. S.D. Schwartz, C.D. Regillo, B.L. Lam, D. Eliott, P.J. Rosenfeld, N.Z. Gregori, J.P. Hubschman, J.L. Davis, G. Heilwell, M. Spirn, J. Maguire, R. Gay, J. Bateman, R.M. Ostrick, D. Morris, M. Vincent, E. Anglade, L.V. Del Priore, and R. Lanza Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies Lancet 385 2015 509 516
170. S.D. Schwartz, J.P. Hubschman, G. Heilwell, V. Franco-Cardenas, C.K. Pan, R.M. Ostrick, E. Mickunas, R. Gay, I. Klimanskaya, and R. Lanza Embryonic stem cell trials for macular degeneration: a preliminary report Lancet 379 2012 713 720
171. R. Sara, and C. David Japan stem-cell trial stirs envy Nature 513 2014 287 288
172. N.D. Radtke, R.B. Aramant, H.M. Petry, P.T. Green, D.J. Pidwell, and M.J. Seiler Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium Am J. Ophthalmol. 146 2008 172 182
173. C.I. Falkner-Radler, I. Krebs, C. Glittenberg, B. Povazay, W. Drexler, A. Graf, and S. Binder Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study Br. J. Ophthalmol. 95 2011 370 375
174. F.K. Chen, G.S. Uppal, R.E. MacLaren, P.J. Coffey, G.S. Rubin, A. Tufail, G.W. Aylward, and L. Da Cruz Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration Clin. Exp. Ophthalmol. 37 2009 275 285
175. A.J. Carr, M.J. Smart, C.M. Ramsden, M.B. Powner, L. da Cruz, and P.J. Coffey Development of human embryonic stem cell therapies for age-related macular degeneration Trends Neurosci. 36 2013 385 395
176. www.thelondonproject.org
177. J. Gust, and T.A. Reh Adult donor rod photoreceptors integrate into the mature mouse retina Invest. Ophthalmol. Vis. Sci. 52 2011 5266 5272
178. B.G. Ballios, M.J. Cooke, L. Donaldson, B.L. Coles, C.M. Morshead, D. van der Kooy, and M.S. Shoichet A hyaluronan-based injectable hydrogel improves the survival and integration of stem cell progeny following transplantation Stem Cell Reports 4 2015 1031 1045
179. J. Lakowski, Y.T. Han, R.A. Pearson, A. Gonzalez-Cordero, E.L. West, S. Gualdoni, A.C. Barber, M. Hubank, R.R. Ali, and J.C. Sowden Effective transplantation of photoreceptor precursor cells selected via cell surface antigen expression Stem Cells 29 2011 1391 1404
180. R.E. MacLaren, R.A. Pearson, A. MacNeil, R.H. Douglas, T.E. Salt, M. Akimoto, A. Swaroop, J.C. Sowden, and R.R. Ali Retinal repair by transplantation of photoreceptor precursors Nature 444 2006 203 207
181. T.A. Reh Neurobiology: right timing for retina repair Nature 444 7116 Nov 9 2006 156 157
182. D. Eberle, T. Kurth, T. Santos-Ferreira, J. Wilson, D. Corbeil, and M. Ader Outer segment formation of transplanted photoreceptor precursor cells PLoS One 7 2012 28
183. K. Warre-Cornish, A.C. Barber, J.C. Sowden, R.R. Ali, and R.A. Pearson Migration, integration and maturation of photoreceptor precursors following transplantation in the mouse retina Stem Cells Dev. 23 2014 941 954
184. R.A. Pearson Advances in repairing the degenerate retina by rod photoreceptor transplantation Biotechnol. Adv. 32 2014 485 491
185. J. Ma, C. Guo, Y. Sun, T. Liao, U. Beattie, F.J. Lopez, D.F. Chen, and K. Lashkari Transplantation of human neural progenitor cells expressing IGF-1 enhances retinal ganglion cell survival PLoS One 10 2015
186. L. Guo, B. Davis, S. Nizari, E.M. Normando, H. Shi, J. Galvao, L. Turner, J. Shi, M. Clements, S. Parrinello, and M.F. Cordeiro Direct optic nerve sheath (DONS) application of schwann cells prolongs retinal ganglion cell survival in vivo Cell Death Dis. 16 2014 399
187. J. Hertz, B. Qu, Y. Hu, R.D. Patel, D.A. Valenzuela, and J.L. Goldberg Survival and integration of developing and progenitor-derived retinal ganglion cells following transplantation Cell Transplant. 23 2014 855 872
188. S. Singhal, B. Bhatia, H. Jayaram, S. Becker, M.F. Jones, P.B. Cottrill, P.T. Khaw, T.E. Salt, and G.A. Limb Human Muller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation Stem Cells Transl. Med. 1 2012 188 199
189. Y. Inoue, A. Iriyama, S. Ueno, H. Takahashi, M. Kondo, Y. Tamaki, M. Araie, and Y. Yanagi Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration Exp. Eye Res. 85 2007 234 241
190. E. Banin, A. Obolensky, M. Idelson, I. Hemo, E. Reinhardtz, E. Pikarsky, T. Ben-Hur, and B. Reubinoff Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells Stem Cells 24 2006 246 257
191. C.B. Mellough, Q. Cui, and A.R. Harvey Treatment of adult neural progenitor cells prior to transplantation affects graft survival and integration in a neonatal and adult rat model of selective retinal ganglion cell depletion Restor. Neurol. Neurosci. 25 2007 177 190
192. T.V. Johnson, and K.R. Martin Cell transplantation approaches to retinal ganglion cell neuroprotection in glaucoma Curr. Opin. Pharmacol. 13 2013 78 82
193. B.G. Ballios, M.J. Cooke, D. van der Kooy, and M.S. Shoichet A hydrogel-based stem cell delivery system to treat retinal degenerative diseases Biomaterials 31 2010 2555 2564
194. M. Tomita, E. Lavik, H. Klassen, T. Zahir, R. Langer, and M.J. Young Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells Stem Cells 23 2005 1579 1588
195. J. Yao, B.A. Tucker, X. Zhang, P. Checa-Casalengua, R. Herrero-Vanrell, and M.J. Young Robust cell integration from co-transplantation of biodegradable MMP2-PLGA microspheres with retinal progenitor cells Biomaterials 32 2011 1041 1050
196. H.J. Klassen, T.F. Ng, Y. Kurimoto, I. Kirov, M. Shatos, P. Coffey, and M.J. Young Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior Invest. Ophthalmol. Vis. Sci. 45 2004 4167 4173
197. M.L. Taddei, E. Giannoni, T. Fiaschi, and P. Chiarugi Anoikis: an emerging hallmark in health and diseases J. Pathol. 226 2012 380 393
198. M.J. Seiler, and R.B. Aramant Cell replacement and visual restoration by retinal sheet transplants Prog. Retin. Eye Res. 31 2012 661 687
199. B. Diniz, P. Thomas, B. Thomas, R. Ribeiro, Y. Hu, R. Brant, A. Ahuja, D. Zhu, L. Liu, M. Koss, M. Maia, G. Chader, D.R. Hinton, and M.S. Humayun Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer Invest. Ophthalmol. Vis. Sci. 54 2013 5087 5096
200. F. Ghosh, O. Rauer, and K. Arner Neuroretinal xenotransplantation to immunocompetent hosts in a discordant species combination Neuroscience 152 2008 526 533
201. V.K. Gullapalli, I.K. Sugino, Y. Van Patten, S. Shah, and M.A. Zarbin Impaired RPE survival on aged submacular human Bruch's membrane Exp. Eye Res. 80 2005 235 248
202. E.L. West, R.A. Pearson, S.E. Barker, U.F. Luhmann, R.E. Maclaren, A.C. Barber, Y. Duran, A.J. Smith, J.C. Sowden, and R.R. Ali Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation Stem Cells 28 2010 1997 2007
203. J. Yao, S.L. Tao, and M.J. Young Synthetic polymer scaffolds for stem cell transplantation in retinal tissue engineering Polymer 3 2011 899
204. R.Y. Tam, T. Fuehrmann, N. Mitrousis, and M.S. Shoichet Regenerative therapies for central nervous system diseases: a biomaterials approach Neuropsychopharmacology 39 2014 169 188
205. M. Inatani, H. Tanihara, A. Oohira, M. Honjo, N. Kido, and Y. Honda Upregulated expression of neurocan, a nervous tissue specific proteoglycan, in transient retinal ischemia Invest. Ophthalmol. Vis. Sci. 41 2000 2748 2754
206. R. Krishnamoorthy, N. Agarwal, and M.H. Chaitin Upregulation of CD44 expression in the retina during the rds degeneration Brain Res. Mol. Brain Res. 77 2000 125 130
207. H. Kim, M.J. Cooke, and M.S. Shoichet Creating permissive microenvironments for stem cell transplantation into the central nervous system Trends Biotechnol. 30 2012 55 63
208. S.R. Hynes, and E.B. Lavik A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space Graefes Arch. Clin. Exp. Ophthalmol. 248 2010 763 778
209. A. Okubo, R.H. Rosa Jr., C.V. Bunce, R.A. Alexander, J.T. Fan, A.C. Bird, and P.J. Luthert The relationships of age changes in retinal pigment epithelium and Bruch's membrane Invest. Ophthalmol. Vis. Sci. 40 1999 443 449
210. H. Cai, and L.V. Del Priore Bruch membrane aging alters the gene expression profile of human retinal pigment epithelium Curr. Eye Res. 31 2006 181 189
211. K. Sun, H. Cai, T.H. Tezel, D. Paik, E.R. Gaillard, and L.V. Del Priore Bruch's membrane aging decreases phagocytosis of outer segments by retinal pigment epithelium Mol. Vis. 13 2007 2310 2319
212. Y. Hu, L. Liu, B. Lu, D. Zhu, R. Ribeiro, B. Diniz, P.B. Thomas, A.K. Ahuja, D.R. Hinton, Y.C. Tai, S.T. Hikita, L.V. Johnson, D.O. Clegg, B.B. Thomas, and M.S. Humayun A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer Ophthalmic Res. 48 2012 186 191
213. K.J. McHugh, S.L. Tao, and M. Saint-Geniez Porous poly(ε-caprolactone) scaffolds for retinal pigment epithelium transplantation Invest. Ophthalmol. Vis. Sci. 55 2014 1754 1762
214. J.T. Lu, C.J. Lee, S.F. Bent, H.A. Fishman, and E.E. Sabelman Thin collagen film scaffolds for retinal epithelial cell culture Biomaterials 28 2007 1486 1494
215. A.E. Sorkio, E.P. Vuorimaa-Laukkanen, H.M. Hakola, H. Liang, T.A. Ujula, J.J. Valle-Delgado, M. Osterberg, M.L. Yliperttula, and H. Skottman Biomimetic collagen I and IV double layer Langmuir-Schaefer films as microenvironment for human pluripotent stem cell derived retinal pigment epithelial cells Biomaterials 51 2015 257 269
216. G. Thumann, A. Viethen, A. Gaebler, P. Walter, S. Kaempf, S. Johnen, and A.K. Salz The in vitro and in vivo behaviour of retinal pigment epithelial cells cultured on ultrathin collagen membranes Biomaterials 30 2009 287 294
217. B.V. Stanzel, Z. Liu, S. Somboonthanakij, W. Wongsawad, R. Brinken, N. Eter, B. Corneo, F.G. Holz, S. Temple, J.H. Stern, and T.A. Blenkinsop Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space Stem Cell Reports 2 2014 64 77
218. P. Xiang, K.C. Wu, Y. Zhu, L. Xiang, C. Li, D.L. Chen, F. Chen, G. Xu, A. Wang, M. Li, and Z.B. Jin A novel Bruch's membrane-mimetic electrospun substrate scaffold for human retinal pigment epithelium cells Biomaterials 35 2014 9777 9788
219. F. Thieltges, B.V. Stanzel, Z. Liu, and F.G. Holz A nanofibrillar surface promotes superior growth characteristics in cultured human retinal pigment epithelium Ophthalmic Res. 46 2011 133 140
220. A.M. Shadforth, K.A. George, A.S. Kwan, T.V. Chirila, and D.G. Harkin The cultivation of human retinal pigment epithelial cells on Bombyx mori silk fibroin Biomaterials 33 2012 4110 4117
221. A.J. Treharne, H.A.J. Thomson, M.C. Grossel, and A.J. Lotery Developing methacrylate-based copolymers as an artificial Bruch's membrane substitute J. Biom. Mater. Res. Part A 100A 2012 2358 2364
222. Z. Liu, N. Yu, F.G. Holz, F. Yang, and B.V. Stanzel Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography Biomaterials 35 2014 2837 2850
223. S. Redenti, S. Tao, J. Yang, P. Gu, H. Klassen, S. Saigal, T. Desai, and M.J. Young Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold J. Ocul. Biol. Dis. Infor. 1 2008 19 29
224. J. Yao, C.W. Ko, P.Y. Baranov, C.V. Regatieri, S. Redenti, B.A. Tucker, J. Mighty, S.L. Tao, and M.J. Young Enhanced differentiation and delivery of mouse retinal progenitor cells using a micropatterned biodegradable thin-film polycaprolactone scaffold Tissue Eng. A 21 2015 1247 1260
225. S. Redenti, W.L. Neeley, S. Rompani, S. Saigal, J. Yang, H. Klassen, R. Langer, and M.J. Young Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation Biomaterials 30 2009 3405 3414
226. Y. Liu, R. Wang, T.I. Zarembinski, N. Doty, C. Jiang, C. Regatieri, X. Zhang, and M.J. Young The application of hyaluronic acid hydrogels to retinal progenitor cell transplantation Tissue Eng. A 19 2013 135 142
227. S. Tao, C. Young, S. Redenti, Y. Zhang, H. Klassen, T. Desai, and M.J. Young Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space Lab Chip 7 2007 695 701
228. A.T. Christiansen, S.L. Tao, M. Smith, G.E. Wnek, J.U. Prause, M.J. Young, H. Klassen, H.J. Kaplan, M. la Cour, and J.F. Kiilgaard Subretinal implantation of electrospun, short nanowire, and smooth poly(ε-caprolactone) scaffolds to the subretinal space of porcine eyes Stem Cells Int. 2012 2012 454295
229. E.B. Lavik, H. Klassen, K. Warfvinge, R. Langer, and M.J. Young Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors Biomaterials 26 2005 3187 3196
230. K. Warfvinge, J.F. Kiilgaard, E.B. Lavik, E. Scherfig, R. Langer, H.J. Klassen, and M.J. Young Retinal progenitor cell xenografts to the pig retina: morphologic integration and cytochemical differentiation Arch. Ophthalmol. 123 2005 1385 1393
231. S. Singh, S. Woerly, and B.J. McLaughlin Natural and artificial substrates for retinal pigment epithelial monolayer transplantation Biomaterials 22 2001 3337 3343
232. A.C. Albertsson, and I.K. Varma Recent developments in ring opening polymerization of lactones for biomedical applications Biomacromolecules 4 2003 1466 1486
233. D. Gupta, C.H. Tator, and M.S. Shoichet Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord Biomaterials 27 2006 2370 2379
234. M.D. Baumann, C.E. Kang, C.H. Tator, and M.S. Shoichet Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury Biomaterials 31 2010 7631 7639
235. T.A. Ahmed, R. Ringuette, V.A. Wallace, and M. Griffith Autologous fibrin glue as an encapsulating scaffold for delivery of retinal progenitor cells Front Bioeng. Biotechnol. 2 2015
236. J. Hertz, R. Robinson, D.A. Valenzuela, E.B. Lavik, and J.L. Goldberg A tunable synthetic hydrogel system for culture of retinal ganglion cells and amacrine cells Acta Biomater. 9 2013 7622 7629
237. K.E. Kador, H.S. Alsehli, A.N. Zindell, L.W. Lau, F.M. Andreopoulos, B.D. Watson, and J.L. Goldberg Retinal ganglion cell polarization using immobilized guidance cues on a tissue-engineered scaffold Acta Biomater. 10 2014 4939 4946
238. K.E. Kador, R.B. Montero, P. Venugopalan, J. Hertz, A.N. Zindell, D.A. Valenzuela, M.S. Uddin, E.B. Lavik, K.J. Muller, F.M. Andreopoulos, and J.L. Goldberg Tissue engineering the retinal ganglion cell nerve fiber layer Biomaterials 34 2013 4242 4250
239. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
240. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 2002 631 651
241. N. Gross, M. Ranjbar, C. Evers, J. Hua, G. Martin, B. Schulze, U. Michaelis, L.L. Hansen, and H.T. Agostini Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes Mol. Vis. 19 2013 54 61
242. S. Liu, C. Chang, M. Verma, D. Hileeto, A. Muntz, U. Stahl, J. Woods, L. Jones, and F. Gu Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome Nano Res. 8 2015 621 635
243. E. Eljarrat-Binstock, and A.J. Domb Iontophoresis: a non-invasive ocular drug delivery J. Control. Release 110 2006 479 489
244. E. Eljarrat-Binstock, F. Orucov, Y. Aldouby, J. Frucht-Pery, and A.J. Domb Charged nanoparticles delivery to the eye using hydrogel iontophoresis J. Control. Release 126 2008 156 161
245. D. Huang, L. Wang, Y. Dong, X. Pan, G. Li, and C. Wu A novel technology using transscleral ultrasound to deliver protein loaded nanoparticles Eur. J. Pharm. Biopharm. 88 2014 104 115
246. J. Park, Y. Zhang, N. Vykhodtseva, J.D. Akula, and N.J. McDannold Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles PLoS One 7 2012 13
247. N. Gooch, R.M. Burr, D.J. Holt, B. Gale, and B. Ambati Design and in vitro biocompatibility of a novel ocular drug delivery device J. Funct. Biomater. 4 2013 14 26
248. R.G. Rubio Long-Acting Anti-VEGF Delivery 2014 Retina Today
249. R.G. Wylie, S. Ahsan, Y. Aizawa, K.L. Maxwell, C.M. Morshead, and M.S. Shoichet Spatially controlled simultaneous patterning of multiple growth factors in three-dimensional hydrogels Nat. Mater. 10 2011 799 806
250. J. Nicolas, S. Mura, D. Brambilla, N. Mackiewicz, and P. Couvreur Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery Chem. Soc. Rev. 42 2013 1147 1235
251. S. Mura, J. Nicolas, and P. Couvreur Stimuli-responsive nanocarriers for drug delivery Nat. Mater. 12 2013 991 1003
252. V. Delplace, and J. Nicolas Degradable vinyl polymers for biomedical applications Nat. Chem. 7 2015 771 784
253. J. Ma, M. Kabiel, B.A. Tucker, J. Ge, and M.J. Young Combining chondroitinase ABC and growth factors promotes the integration of murine retinal progenitor cells transplanted into Rho(-/-) mice Mol. Vis. 17 2011 1759 1770